Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Esperion Therapeutics, Inc. (ESPR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Drug Manufacturers—Specialty & Generic
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
20 Sep 2023
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
68,318
-1%
742
$1.25
$923.79
SELL
18 Aug 2023
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
69,060
-0%
243
$1.41
$343.60
SELL
21 Jun 2023
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
69,409
-0%
603
$1.48
$894.25
SELL
17 May 2023
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
70,012
-0%
219
$1.62
$355.66
SELL
19 Apr 2023
Looker Benjamin
General Counsel, Officer
Esperion Therapeutics, Inc.
(ESPR)
83,663
-1%
1,290
$1.27
$1,640.88
SELL
19 Apr 2023
Foody Joanne M.
Chief Medical Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
127,064
-0%
938
$1.27
$1,192.20
SELL
19 Apr 2023
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
70,231
-0%
115
$1.28
$146.97
SELL
17 Mar 2023
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
70,346
-0%
526
$1.78
$937.49
SELL
17 Mar 2023
Koenig Sheldon L.
President and CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
292,816
-2%
6,999
$1.78
$12,479.22
SELL
17 Mar 2023
Foody Joanne M.
Chief Medical Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
128,002
-2%
3,808
$1.78
$6,785.48
SELL
18 Jan 2023
Foody Joanne M.
Chief Medical Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
106,944
-1%
1,191
$6.99
$8,319.14
SELL
18 Jan 2023
Looker Benjamin
General Counsel, Officer
Esperion Therapeutics, Inc.
(ESPR)
64,453
-8%
6,347
$7.00
$44,403.61
SELL
18 Oct 2022
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
53,662
-0%
107
$7.69
$822.83
SELL
18 Oct 2022
Foody Joanne M.
Chief Medical Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
108,135
-0%
942
$7.69
$7,242.10
BUY
31 Aug 2022
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
54,024
+1%
1,000
$7.46
$7,460.00
SELL
17 Aug 2022
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
53,024
-0%
199
$6.82
$1,356.19
BUY
5 Aug 2022
Koenig Sheldon L.
President and CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
198,771
+4%
8,606
$5.80
$49,950.09
SELL
19 Jul 2022
Foody Joanne M.
Chief Medical Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
109,077
-3%
3,901
$6.55
$25,551.55
SELL
19 Jul 2022
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
53,223
-0%
431
$6.58
$2,836.84
SELL
17 Jun 2022
Koenig Sheldon L.
President and CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
190,165
-2%
4,552
$4.99
$22,719.03
SELL
17 Jun 2022
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
53,654
-0%
256
$4.90
$1,254.40
BUY
2 Jun 2022
CARROLL J MARTIN
Director
Esperion Therapeutics, Inc.
(ESPR)
5,000
+100%
5,000
$5.64
$28,179.50
SELL
17 May 2022
Warren Eric
Chief Commercial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
53,910
-0%
196
$5.98
$1,172.28
SELL
17 Mar 2022
Koenig Sheldon L.
President and CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
194,717
-0%
571
$4.58
$2,615.18
BUY
24 May 2021
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
4,477,964
+2%
100,000
$20.22
$2,021,620.00
BUY
19 May 2021
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
4,377,964
+4%
200,000
$20.37
$4,073,960.00
BUY
5 May 2021
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
4,177,964
+5%
230,000
$20.21
$4,648,482.00
BUY
3 Nov 2020
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,947,964
+5%
200,000
$25.31
$5,062,120.00
BUY
11 Mar 2020
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
111,998
+2%
2,500
$43.00
$107,500.00
BUY
28 Feb 2020
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
109,498
+4%
5,000
$49.00
$245,000.00
BUY
23 Jan 2020
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,747,964
+0%
20,000
$52.12
$1,042,398.00
BUY
6 Nov 2019
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,727,964
+2%
75,000
$37.30
$2,797,560.00
BUY
6 Nov 2019
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
83,663
+6%
5,000
$36.98
$184,900.00
BUY
4 Sep 2019
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,652,964
+2%
80,000
$33.78
$2,702,208.00
BUY
4 Sep 2019
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
78,663
+10%
7,500
$34.55
$259,106.61
BUY
1 Aug 2019
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
71,163
+7%
5,000
$39.56
$197,800.00
BUY
23 Jul 2019
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,572,964
+1%
50,000
$42.65
$2,132,565.00
BUY
28 Jun 2019
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
66,163
+8%
5,000
$46.00
$230,000.00
BUY
3 Apr 2019
Bartram Richard
Chief Financial Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
12,592
+174%
8,000
$42.88
$343,045.00
BUY
29 Mar 2019
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
61,163
+8%
5,000
$40.00
$200,000.00
BUY
20 Mar 2019
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
56,163
+9%
5,000
$43.48
$217,400.00
SELL
19 Mar 2019
VITULLO NICOLE
Director
Esperion Therapeutics, Inc.
(ESPR)
1,700
-90%
15,329
$44.73
$685,596.10
BUY
14 Mar 2019
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,522,964
+1%
50,000
$49.89
$2,494,355.00
BUY
14 Mar 2019
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
51,163
+10%
5,000
$48.73
$243,650.00
SELL
12 Mar 2019
NEWTON ROGER S
Director
Esperion Therapeutics, Inc.
(ESPR)
548,726
-4%
25,000
$50.06
$1,251,500.00
BUY
4 Jan 2019
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,472,964
+2%
80,000
$41.29
$3,303,256.00
BUY
24 Dec 2018
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,392,964
+1%
50,000
$39.91
$1,995,725.00
BUY
17 Dec 2018
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,342,964
+1%
60,000
$47.73
$2,864,070.00
SELL
2 Nov 2018
Boxer Capital, LLC
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
1,134,750
-8%
100,000
$56.38
$5,638,343.00
SELL
1 Nov 2018
NEWTON ROGER S
Director
Esperion Therapeutics, Inc.
(ESPR)
573,726
-0%
2,827
$50.07
$141,548.52
SELL
16 Oct 2018
NEWTON ROGER S
Director
Esperion Therapeutics, Inc.
(ESPR)
576,553
-3%
22,173
$50.02
$1,108,997.40
SELL
27 Aug 2018
NEWTON ROGER S
Director
Esperion Therapeutics, Inc.
(ESPR)
615,726
-2%
17,700
$51.05
$903,610.00
SELL
17 Aug 2018
NEWTON ROGER S
Director
Esperion Therapeutics, Inc.
(ESPR)
616,426
-1%
7,300
$50.06
$365,438.00
BUY
3 Aug 2018
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,282,964
+1%
50,000
$46.14
$2,306,970.00
BUY
12 Jul 2018
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,232,964
+1%
50,000
$41.77
$2,088,300.00
BUY
29 Jun 2018
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,182,964
+1%
50,000
$39.48
$1,973,805.00
BUY
21 Jun 2018
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,132,964
+1%
60,000
$38.57
$2,314,224.00
BUY
7 Jun 2018
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,072,964
+1%
60,000
$37.79
$2,267,292.00
BUY
5 Jun 2018
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
3,012,964
+2%
60,000
$38.47
$2,308,440.00
BUY
18 May 2018
BIOTECH TARGET N V
10% Owner
Esperion Therapeutics, Inc.
(ESPR)
2,952,964
+4%
130,000
$40.11
$5,213,770.00
BUY
29 Mar 2018
NEWTON ROGER S
Director
Esperion Therapeutics, Inc.
(ESPR)
639,682
+1%
6,912
$72.37
$484,149.88
SELL
24 Jan 2018
VITULLO NICOLE
Director
Esperion Therapeutics, Inc.
(ESPR)
15,329
-43%
11,674
$71.79
$838,076.50
SELL
6 Dec 2017
VITULLO NICOLE
Director
Esperion Therapeutics, Inc.
(ESPR)
25,927
-26%
9,326
$53.85
$502,205.10
SELL
21 Mar 2017
JANNEY DANIEL
Director
Esperion Therapeutics, Inc.
(ESPR)
1,588,627
-18%
350,000
$45.80
$16,029,263.00
SELL
21 Mar 2017
GOLDSTEIN DOV A MD
Director
Esperion Therapeutics, Inc.
(ESPR)
837,125
-48%
800,000
$41.66
$33,327,088.00
BUY
21 Mar 2017
OMENN GILBERT S
Director
Esperion Therapeutics, Inc.
(ESPR)
1,000
+100%
1,000
$42.26
$42,260.00
BUY
1 Nov 2016
Lalwani Narendra D.
Chief Operating Officer, Officer
Esperion Therapeutics, Inc.
(ESPR)
5,000
+100%
5,000
$9.93
$49,650.00
BUY
5 Jul 2016
MCGOVERN MARK E
Director
Esperion Therapeutics, Inc.
(ESPR)
5,000
+100%
5,000
$10.00
$50,000.00
BUY
4 May 2016
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
41,614
+20%
7,000
$14.85
$103,950.00
BUY
1 Mar 2016
OMENN GILBERT S
Director
Esperion Therapeutics, Inc.
(ESPR)
10,000
+100%
5,000
$15.28
$76,400.00
BUY
27 Jan 2016
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
34,614
+11%
3,600
$15.88
$57,168.00
BUY
15 Jan 2016
MAYLEBEN TIMOTHY M
President & CEO, Director, Officer
Esperion Therapeutics, Inc.
(ESPR)
31,014
+30%
7,200
$14.08
$101,376.00
Home